Ledger.Open graph →

SEC Form D · Amendment · filed July 5, 2011

CORONADO BIOSCIENCES INC

Offering

$28.8M

Sold

$25.8M

Exemption

—

Industry

Pharmaceuticals

Location

NEW YORK, NY

Type

—

People & firms on this filing (18)

J. J. Lobell · New York, NYDirector Bobby W. Sandage · New York, NYExec · Director David J. Barrett · New York, NYDirector Jimmie Harvey · New York, NYDirector Glenn L. Cooper · New York, NYExec · Director Michael W. Rogers · New York, NYDirector Dale Ritter · New York, NYExec Eric K. Rowinsky · New York, NYDirector Lindsay A. Rosenwald · New York, NYDirector Fred J. Dyment · Calgary, Alberta, CanadaDirector Gregory C. Stevenson · Calgary, Alberta, CanadaDirector James C. Houck · Calgary, Alberta, CanadaDirector Randall Oliphant · Calgary, Alberta, CanadaExec · Director William Wallace · Calgary, Alberta, CanadaDirector Neel T. Kashkari · NEWPORT BEACH, CAExec · Director Mark R. Kiesel · NEWPORT BEACH, CAExec David C. Lown · NEWPORT BEACH, CADirector Scott A. Mather · NEWPORT BEACH, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗